DVAX: Good, very positive CEO presentation at yesterday's J.P. Morgan Healthcare Conference. Seemed to suggest (unclear on this) that they're expecting either a full approval or a restricted approval by the FDA on Feb. 24, not a CRL.
I'm starting to change my opinion on that possibility, think it's a pretty decent risk/reward at around $3
All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius